샘플 요청 목록

 카트 문의
시장보고서
상품코드
1993872

차세대 바이오 제조 시장 : 워크플로우별, 용도별, 제품 유형별, 최종 용도별, 국가별, 지역별 - 세계 산업 분석, 시장 규모, 시장 점유율 및 예측(2026-2033년)

Next-Generation Biomanufacturing Market, By Workflow Type, By Application, By Product, By End Use, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
발행일: | 리서치사: 구분자 AnalystView Market Insights | 페이지 정보: 영문 387 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

차세대 바이오 제조 시장 규모는 2025년에 443억 8,039만 달러로 평가되었으며, 2026년부터 2033년까지 CAGR 6.81%로 확대될 것으로 전망됩니다.

차세대 바이오 제조란 백신, 단클론항체, 유전자 치료제, 기타 바이오의약품 등의 생물학적 제제를 생산하기 위해 첨단 기술과 최신 생산기법을 활용하는 것을 말합니다. 일반적으로 시간이 많이 걸리는 대규모 배치 공정에 의존하는 전통적인 바이오 제조와 달리, 이러한 접근 방식은 보다 유연하고 효율적이며 확장 가능한 생산 시스템에 중점을 둡니다. 연속 바이오프로세스, 일회용 바이오리액터, 자동화, 디지털 모니터링, 첨단 세포 배양 기술 등의 기술은 제조 효율을 높이고 제품 품질의 일관성을 유지하면서 종양학, 희귀질환, 맞춤의료 등의 분야에서 사용되는 복잡한 생물학적 제제에 대한 수요 증가를 뒷받침하고 있습니다. 생물학적 제제에 대한 수요가 지속적으로 증가하고, 제약기업들이 특수한 제조 공정을 지원하기 위해 첨단 제조 기술을 채택함에 따라 차세대 바이오 제조 시장은 꾸준히 발전하고 있습니다. 또한, 생명공학 연구개발에 대한 투자 확대, 바이오의약품 제조 시설의 확장, 생명공학 기업과 위탁생산업체(CMO)와의 제휴는 현대의 바이오의약품 제조에 이러한 기술이 더욱 광범위하게 적용될 수 있도록 뒷받침하고 있습니다.

차세대 바이오 제조 시장 - 시장 역학

생물학적 제제 및 첨단 치료법에 대한 전 세계 수요 증가

차세대 바이오 제조 시장을 이끄는 주요 요인은 단클론항체, 백신, 유전자 및 세포 치료제를 포함한 생물학적 제제에 대한 전 세계 수요의 급속한 확대입니다. 암, 자가면역질환, 감염성 질환과 같은 질병에 대해 헬스케어 시스템이 첨단 생물학적 치료에 점점 더 의존함에 따라 제약업체들은 보다 효율적이고 확장성이 높은 생산 기술을 필요로 하고 있습니다. 연속 공정, 자동화, 모듈식 제조 시스템 등 차세대 바이오 제조 방식은 기존 일괄 생산 방식에 비해 생산 주기 단축, 제품 품질 향상, 보다 유연한 운영을 가능하게 합니다. 이러한 수요 증가는 연속 업스트림 바이오 제조 부문을 강화하고 있으며, 이 부문은 운영 효율성 향상과 시설 면적 감소를 통해 대규모 바이오의약품 생산을 지원함으로써 시장을 주도하고 있습니다. 이 부문은 전체 시장의 약 45.3%를 차지하고 있습니다. 정부 및 세계 보건 데이터도 바이오의약품 생산의 중요성이 커지고 있음을 강조하고 있습니다. 세계보건기구(WHO)에 따르면, 유연하고 모듈화된 생산기술에 대한 투자로 전 세계 바이오의약품 생산능력은 30% 이상 확대되었습니다. 한편, 미국 국립보건원(NIH)은 연속 바이오프로세싱을 통해 제조 사이클 시간을 최대 50%까지 단축할 수 있으며, 바이오의약품 생산의 효율성을 크게 향상시킬 수 있다고 보고했습니다. 이러한 추세는 바이오의약품에 대한 수요 증가와 첨단 제조 인프라에 대한 정부 투자 확대가 차세대 바이오 제조 기술의 세계 보급을 가속화하고 있음을 보여줍니다.

차세대 바이오 제조 시장 - 시장 세분화 분석:

세계 차세대 바이오 제조 시장은 제품, 응용 분야, 워크플로우 유형, 최종 용도, 지역별로 세분화되어 있습니다.

시장은 제품을 기준으로 연속식 업스트림 바이오 제조 제품, 일회용 업스트림 바이오 제조 제품, 다운스트림 바이오 제조 제품의 세 가지 범주로 나뉩니다. 일회용 업스트림 바이오 제조 제품 부문이 세계 차세대 바이오 제조 시장을 주도하고 있습니다. 일회용 업스트림 바이오 제조 제품은 주로 오염 위험 감소, 운영 비용 절감, 제조 유연성 향상이라는 장점에 의해 주도되고 있습니다. 일회용 바이오리액터, 일회용 백, 튜브 시스템 등을 포함한 이 제품들은 기존의 스테인리스 스틸 시스템에서 필요했던 복잡한 세척 및 멸균 과정이 필요하지 않습니다. 이러한 장점은 생산 주기를 크게 단축하고 효율성을 향상시킵니다. 이는 단클론항체, 백신, 세포 치료제, 유전자 치료제 등을 생산하는 바이오제약 기업에게 매우 중요합니다. 미국 식품의약국(FDA)에 따르면, 최근 몇 년 동안 승인된 생물학적 제제 및 바이오시밀러 제품의 수가 꾸준히 증가하여 보다 신속하고 적응력이 높은 제조 플랫폼에 대한 수요를 주도하고 있습니다. 또한, 국제제약협회연맹(IFPMA)의 보고서에 따르면, 생물학적 제제는 전 세계 의약품 파이프라인에서 빠르게 점유율을 확대하고 있으며, 제조업체들이 생산을 가속화하고 신속하게 규모를 확대하기 위해 일회용 기술을 채택하도록 장려하고 있습니다. 이러한 장점으로 인해 일회용 업스트림 공정 시스템은 전 세계 차세대 바이오 제조 시설에서 가장 널리 채택되고 있는 제품 카테고리입니다.

시장은 용도에 따라 단클론항체, 백신, 재조합 단백질, 호르몬 등 크게 두 가지 범주로 나뉩니다. 단클론항체(mAbs)가 선두를 달리고 있는 주요 요인은 암, 자가면역질환, 감염성 질환의 치료에 광범위하게 사용되고 있기 때문입니다. 바이오제약기업들은 단클론항체의 높은 특이성, 강력한 치료 효과, 세계 승인 건수 증가를 배경으로 개발에 점점 더 많은 우선순위를 부여하고 있습니다. 미국 식품의약국(FDA)에 따르면, 최근 몇 년 동안 승인된 생물학적 제제 중 단클론항체가 큰 비중을 차지하고 있으며, 이는 항체치료에 대한 세계 수요 증가를 반영하고 있습니다. 또한, 세계보건기구(WHO)는 종양학 및 면역 관련 질환에 대한 단클론항체 치료의 활용 확대를 강조하고 있으며, 이에 따라 대규모의 효율적인 바이오 제조 플랫폼에 대한 요구가 증가하고 있습니다. 이러한 치료법은 고도로 관리되고 확장 가능한 제조 공정이 필요하기 때문에 제조업체들은 업스트림 및 다운스트림 공정에서 첨단 바이오 제조 기술을 점점 더 많이 채택하고 있으며, 그 결과 세계 시장에서 단클론항체 부문의 우위가 더욱 강화되고 있습니다.

차세대 바이오 제조 시장 - 지역별 인사이트

차세대 바이오 제조 시장은 지리적으로 크게 확대되고 있으며, 북미는 탄탄한 생명공학 및 제약 기업, 선진적인 연구 인프라, 지원적인 규제 체계로 인해 차세대 바이오 제조 시장에서 상당한 점유율을 차지하고 있습니다. 미국은 바이오의약품, 세포 및 유전자 치료제 개발, 연속 바이오 공정 및 일회용 시스템과 같은 최신 제조 기술에 대한 투자를 통해 이 지역에 큰 기여를 하고 있습니다. 미국 보건복지부와 국립보건원(NIH) 등의 정부 프로그램 및 자금 지원도 첨단 바이오 제조 역량 개발을 지원하고 있습니다. 한편, 유럽은 고도로 발달한 제약 산업과 공동 연구 이니셔티브에 힘입어 시장에서 중요한 지역으로 부상하고 있습니다. 독일, 영국, 스위스, 프랑스 등의 국가들은 바이오의약품 생산 및 바이오의약품 연구에 참여하고 있으며, 정부 프로그램, 학술기관 및 위탁개발생산기관(CDMO)이 지역 전체에 차세대 바이오 제조 기술을 꾸준히 도입하는 데 기여하고 차세대 바이오 제조 분야에서 이 지역의 중요성을 높이고 있습니다. 중요도를 높이고 있습니다.

차세대 바이오 제조 시장 - 국가별 인사이트

세계 차세대 바이오 제조 시장에서 미국은 탄탄한 생명공학 산업, 첨단 연구 인프라, 바이오의약품 제조 기술에 대한 지속적인 투자로 차세대 바이오 제조 시장의 주요 국가로 부상하고 있습니다. 이 나라에는 바이오의약품, 백신, 세포 및 유전자 치료제의 개발 및 생산을 지원하는 수많은 바이오제약 기업, 연구기관 및 위탁개발생산기관(CDMO)이 있습니다. 정부의 노력도 시장 발전에 기여하고 있습니다. 예를 들어, 미국 보건복지부는 국내 바이오 제조 역량을 강화하고 첨단 제조 기술의 혁신을 촉진하기 위한 프로그램을 지원해 왔습니다. 또한, 학계, 생명공학 기업, 연구기관 간의 협력을 통해 연속처리, 자동화, 일회용 바이오프로세싱 시스템 등 차세대 바이오 제조 기법의 단계적 도입을 지원하고 있습니다.

목차

제1장 차세대 바이오 제조 시장 개요

제2장 주요 요약

제3장 차세대 바이오 제조 주요 시장 동향

제4장 차세대 바이오 제조 산업 분석

제5장 차세대 바이오 제조 시장 : 높아지는 지정학적 긴장의 영향

제6장 차세대 바이오 제조 시장 구도

제7장 차세대 바이오 제조 시장 : 워크플로우 유형별

제8장 차세대 바이오 제조 시장 : 용도별

제9장 차세대 바이오 제조 시장 : 제품별

제10장 차세대 바이오 제조 시장 : 최종사용별

제11장 차세대 바이오 제조 시장 : 지역별

제11장 주요 벤더 분석 : 차세대 바이오 제조 산업

제12장 AnalystView 전방위 전망

KSM 26.04.15

Next-Generation Biomanufacturing Market size was valued at US$ 44,380.39 Million in 2025, expanding at a CAGR of 6.81% from 2026 to 2033.

Next-generation biomanufacturing refers to the use of advanced technologies and modern production methods to produce biological products such as vaccines, monoclonal antibodies, gene therapies, and other biopharmaceuticals. Unlike traditional biomanufacturing, which typically relies on large and time-intensive batch processes, these approaches emphasize more flexible, efficient, and scalable production systems. Technologies such as continuous bioprocessing, single-use bioreactors, automation, digital monitoring, and advanced cell-culture techniques help improve manufacturing efficiency and maintain consistent product quality while supporting the increasing demand for complex biologic medicines used in areas such as oncology, rare diseases, and personalized medicine. The Next-Generation Biomanufacturing market is developing steadily as demand for biologic drugs continues to increase and pharmaceutical companies adopt advanced manufacturing technologies to support specialized production processes. In addition, growing investments in biotechnology research, expansion of biopharmaceutical manufacturing facilities, and collaborations between biotechnology firms and contract manufacturing organizations are supporting the wider adoption of these technologies in modern biopharmaceutical production.

Next-Generation Biomanufacturing Market- Market Dynamics

Rising Global Demand for Biologics and Advanced Therapies

A major factor driving the Next-Generation Biomanufacturing Market is the rapidly growing global demand for biologic medicines, including monoclonal antibodies, vaccines, and gene and cell therapies. As healthcare systems increasingly rely on advanced biologic treatments for diseases such as cancer, autoimmune disorders, and infectious conditions, pharmaceutical manufacturers require more efficient and scalable production technologies. Next-generation biomanufacturing methods, including continuous processing, automation, and modular manufacturing systems, enable faster production cycles, higher product quality, and more flexible operations compared with traditional batch manufacturing. This rising demand has strengthened the continuous upstream biomanufacturing segment, which leads the market because it supports large-scale biologics production with improved operational efficiency and a smaller facility footprint. This segment represented approximately 45.3% of the total market share. Government and global health data also emphasize the growing significance of biologics production. According to the World Health Organization (WHO), global biopharmaceutical manufacturing capacity has expanded by over 30% due to investments in flexible and modular production technologies, while the U.S. National Institutes of Health (NIH) reports that continuous bioprocessing can reduce manufacturing cycle times by up to 50%, significantly enhancing efficiency in biologic drug production. These developments indicate that increasing demand for biologics and rising government investment in advanced manufacturing infrastructure are accelerating the global adoption of next-generation biomanufacturing technologies.

Next-Generation Biomanufacturing Market- Segmentation Analysis:

The Global Next-Generation Biomanufacturing Market is segmented on the basis of Product, Application, Workflow Type, End Use, and Region.

The market is divided into three categories based on Product: Continuous Upstream Biomanufacturing Products, Single-Use Upstream Biomanufacturing Products, and Downstream Biomanufacturing Products. The Single-Use Upstream Biomanufacturing Products segment controls the global Next-Generation Biomanufacturing market single-use upstream biomanufacturing products are primarily driven by their ability to reduce contamination risks, lower operational costs, and increase manufacturing flexibility. These products, including disposable bioreactors, single-use bags, and tubing systems, eliminate the need for complex cleaning and sterilization processes required in traditional stainless-steel systems. This advantage significantly shortens production cycles and improves efficiency, which is critical for biopharmaceutical companies producing monoclonal antibodies, vaccines, and cell or gene therapies. According to the U.S. Food and Drug Administration, the number of approved biologics and biosimilar products has increased steadily in recent years, driving demand for faster and more adaptable manufacturing platforms. Additionally, the International Federation of Pharmaceutical Manufacturers & Associations reports that biologics represent a rapidly growing share of global pharmaceutical pipelines, encouraging manufacturers to adopt single-use technologies to accelerate production and scale up quickly. These advantages make single-use upstream systems the most widely adopted product category in next-generation biomanufacturing facilities worldwide.

The market is divided into two categories based on application: Monoclonal Antibodies, Vaccines, Recombinant Proteins, and Hormones. The leadership of monoclonal antibodies (mAbs) is mainly driven by their extensive use in the treatment of cancer, autoimmune disorders, and infectious diseases. Biopharmaceutical companies increasingly prioritize monoclonal antibody development due to their high specificity, strong therapeutic effectiveness, and growing regulatory approvals worldwide. According to the U.S. Food and Drug Administration, monoclonal antibodies account for a significant share of newly approved biologic drugs in recent years, reflecting strong global demand for antibody-based therapies. In addition, the World Health Organization highlights the expanding use of monoclonal antibody treatments in oncology and immune-related diseases, which has increased the need for large-scale and efficient biomanufacturing platforms. Because these therapies require highly controlled and scalable production processes, manufacturers are increasingly adopting advanced upstream and downstream biomanufacturing technologies, thereby strengthening the dominance of the monoclonal antibodies segment in the global market.

Next-Generation Biomanufacturing Market- Geographical Insights

The Next-Generation Biomanufacturing Market shows strong geographical expansion, with North America holding a notable share of the Next-Generation Biomanufacturing market due to the presence of established biotechnology and pharmaceutical companies, advanced research infrastructure, and supportive regulatory systems. The United States contributes significantly to the region through investments in biologics, cell and gene therapy development, and modern manufacturing technologies such as continuous bioprocessing and single-use systems. Government programs and funding from organizations such as the U.S. Department of Health and Human Services and the National Institutes of Health also support the development of advanced biomanufacturing capabilities. At the same time, Europe represents an important region in the market, supported by a well-developed pharmaceutical industry and collaborative research initiatives. Countries including Germany, the United Kingdom, Switzerland, and France are involved in biologics production and biopharmaceutical research, while government programs, academic institutions, and contract development and manufacturing organizations contribute to the steady adoption of next-generation biomanufacturing technologies across the region, strengthening the region's importance in next-generation.

Next-Generation Biomanufacturing Market- Country Insights

In the global Next-Generation Biomanufacturing Market, The United States represents a key country in the Next-Generation Biomanufacturing market due to its well-established biotechnology industry, advanced research infrastructure, and continuous investment in biologics manufacturing technologies. The country hosts numerous biopharmaceutical companies, research institutions, and contract development and manufacturing organizations that support the development and production of biologics, vaccines, and cell and gene therapies. Government initiatives also contribute to market development; for example, the U.S. Department of Health and Human Services has supported programs to strengthen domestic biomanufacturing capabilities and encourage innovation in advanced manufacturing technologies. In addition, collaboration between academic institutions, biotechnology firms, and research organizations supports the gradual adoption of next-generation biomanufacturing methods such as continuous processing, automation, and single-use bioprocessing systems.

Next-Generation Biomanufacturing Market- Competitive Landscape:

The Next-Generation Biomanufacturing Market is intensely competitive and moderately fragmented, with numerous global biotechnology and life sciences companies emphasizing technological innovation, automation, and advanced bioprocessing solutions to enhance their market position. Prominent companies, including Thermo Fisher Scientific, Merck KGaA, Danaher Corporation, Sartorius AG, and GE HealthCare, play a crucial role in the industry by providing sophisticated bioreactors, disposable manufacturing systems, and automated platforms for biologics production. These organizations implement strategies such as collaborations, new product introductions, capacity expansions, and strategic acquisitions to enhance manufacturing productivity and scalability. Additionally, key companies are increasingly investing in continuous biomanufacturing technologies, AI-enabled process monitoring, and flexible modular production facilities to meet the rising demand for biologics, biosimilars, and cell and gene therapies globally, thereby intensifying market competition and driving technological progress across the sector.

Recent Developments:

In March 2023, Sartorius AG and LFB Biomanufacturing collaborated on the creation and production of cell lines. LFB BIOMANUFACTURING is a division of LFB Group, a well-known European business that supplies medical practitioners with plasma-derived pharmaceutical products. It specializes in therapeutic protein biomanufacturing. This collaboration strengthens advanced cell line development capabilities and supports the growing demand for efficient biologics manufacturing across the global biopharmaceutical industry.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Applikon Biotechnology BV (Netherlands),
  • bbi-biotech GmbH (Germany),
  • Danaher Corporation (US),
  • Eppendorf AG (Germany), Esco Group of Companies (US),
  • GEA Group Aktiengesellschaft (Germany),
  • Meissner Filtration Products, Inc. (US),
  • Merck KGaA (Germany),
  • PBS Biotech, Inc. (US),
  • Pierre Guerin (France),
  • Sartorius AG (Germany),
  • Shanghai Bailun Biotechnology Co. Ltd. (China),
  • Solaris Biotechnology Srl. (Italy),
  • Thermo Fisher Scientific Inc. (US),
  • ZETA GmbH (Austria),
  • Others

GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET, BY WORKFLOW TYPE- MARKET ANALYSIS, 2020 - 2033

  • Upstream Biomanufacturing Workflow
  • Downstream Biomanufacturing Workflow

GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033

  • Monoclonal Antibodies
  • Vaccines
  • Recombinant Protein
  • Hormones
  • Others

GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET, BY PRODUCT- MARKET ANALYSIS, 2020 - 2033

  • Continuous Upstream Biomanufacturing Products
  • Single-Use Upstream Biomanufacturing Products
  • Downstream Biomanufacturing Products

GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET, BY End Use- MARKET ANALYSIS, 2020 - 2033

  • Biopharmaceutical Companies
  • Research Institutions
  • Contract Research Organizations

GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Next-Generation Biomanufacturing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Next-Generation Biomanufacturing Market Snippet by Workflow Type
    • 2.1.2. Next-Generation Biomanufacturing Market Snippet by Application
    • 2.1.3. Next-Generation Biomanufacturing Market Snippet by Product
    • 2.1.4. Next-Generation Biomanufacturing Market Snippet by End Use
    • 2.1.5. Next-Generation Biomanufacturing Market Snippet by Country
    • 2.1.6. Next-Generation Biomanufacturing Market Snippet by Region
  • 2.2. Competitive Insights

3. Next-Generation Biomanufacturing Key Market Trends

  • 3.1. Next-Generation Biomanufacturing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Next-Generation Biomanufacturing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Next-Generation Biomanufacturing Market Opportunities
  • 3.4. Next-Generation Biomanufacturing Market Future Trends

4. Next-Generation Biomanufacturing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Next-Generation Biomanufacturing Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Next-Generation Biomanufacturing Market Landscape

  • 6.1. Next-Generation Biomanufacturing Market Share Analysis, 2025
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Next-Generation Biomanufacturing Market - By Workflow Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Workflow Type, 2025 & 2033 (%)
    • 7.1.2. Upstream Biomanufacturing Workflow
    • 7.1.3. Downstream Biomanufacturing Workflow

8. Next-Generation Biomanufacturing Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
    • 8.1.2. Monoclonal Antibodies
    • 8.1.3. Vaccines
    • 8.1.4. Recombinant Protein
    • 8.1.5. Hormones
    • 8.1.6. Others

9. Next-Generation Biomanufacturing Market - By Product

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Product, 2025 & 2033 (%)
    • 9.1.2. Continuous Upstream Biomanufacturing Products
    • 9.1.3. Single-Use Upstream Biomanufacturing Products
    • 9.1.4. Downstream Biomanufacturing Products

10. Next-Generation Biomanufacturing Market - By End Use

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
    • 10.1.2. Biopharmaceutical Companies
    • 10.1.3. Research Institutions
    • 10.1.4. Contract Research Organizations

11. Next-Generation Biomanufacturing Market- By Geography

  • 10.2. Introduction
    • 10.2.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
  • 10.3. North America
    • 10.3.1. Overview
    • 10.3.2. Next-Generation Biomanufacturing Key Manufacturers in North America
    • 10.3.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.3.4. North America Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
    • 10.3.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.3.6. North America Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 10.3.7. North America Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.3.8. U.S.
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.8.3. U.S. Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.3.8.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.8.5. U.S. Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.3.8.6. U.S. Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.3.9. Canada
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.9.3. Canada Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.3.9.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.9.5. Canada Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.3.9.6. Canada Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 10.4. Europe
    • 10.4.1. Overview
    • 10.4.2. Next-Generation Biomanufacturing Key Manufacturers in Europe
    • 10.4.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.4.4. Europe Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
    • 10.4.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.4.6. Europe Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 10.4.7. Europe Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.4.8. Germany
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.8.3. Germany Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.4.8.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.8.5. Germany Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.4.8.6. Germany Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.4.9. UK
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.9.3. UK Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.4.9.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.9.5. UK Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.4.9.6. UK Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.4.10. France
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.10.3. France Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.4.10.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.10.5. France Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.4.10.6. France Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.4.11. Italy
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.11.3. Italy Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.4.11.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.11.5. Italy Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.4.11.6. Italy Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.4.12. Spain
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.12.3. Spain Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.4.12.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.12.5. Spain Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.4.12.6. Spain Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.4.13. The Netherlands
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.13.3. The Netherlands Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.4.13.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.13.5. The Netherlands Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.4.13.6. The Netherlands Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.4.14. Sweden
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.14.3. Sweden Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.4.14.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.14.5. Sweden Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.4.14.6. Sweden Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.4.15. Russia
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.15.3. Russia Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.4.15.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.15.5. Russia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.4.15.6. Russia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.4.16. Poland
      • 10.4.16.1. Overview
      • 10.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.16.3. Poland Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.4.16.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.16.5. Poland Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.4.16.6. Poland Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.4.17. Rest of Europe
      • 10.4.17.1. Overview
      • 10.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.17.3. Rest of the Europe Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.4.17.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.17.5. Rest of the Europe Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.4.17.6. Rest of the Europe Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 10.5. Asia Pacific (APAC)
    • 10.5.1. Overview
    • 10.5.2. Next-Generation Biomanufacturing Key Manufacturers in Asia Pacific
    • 10.5.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.5.4. APAC Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
    • 10.5.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.5.6. APAC Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 10.5.7. APAC Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.5.8. China
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.8.3. China Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.5.8.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.8.5. China Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.5.8.6. China Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.5.9. India
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.9.3. India Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.5.9.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.9.5. India Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.5.9.6. India Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.5.10. Japan
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.10.3. Japan Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.5.10.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.10.5. Japan Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.5.10.6. Japan Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.5.11. South Korea
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.11.3. South Korea Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.5.11.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.11.5. South Korea Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.5.11.6. South Korea Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.5.12. Australia
      • 10.5.12.1. Overview
      • 10.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.12.3. Australia Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.5.12.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.12.5. Australia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.5.12.6. Australia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.5.13. Indonesia
      • 10.5.13.1. Overview
      • 10.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.13.3. Indonesia Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.5.13.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.13.5. Indonesia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.5.13.6. Indonesia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.5.14. Thailand
      • 10.5.14.1. Overview
      • 10.5.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.14.3. Thailand Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.5.14.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.14.5. Thailand Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.5.14.6. Thailand Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.5.15. Philippines
      • 10.5.15.1. Overview
      • 10.5.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.15.3. Philippines Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.5.15.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.15.5. Philippines Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.5.15.6. Philippines Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.5.16. Rest of APAC
      • 10.5.16.1. Overview
      • 10.5.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.16.3. Rest of APAC Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.5.16.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.16.5. Rest of APAC Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.5.16.6. Rest of APAC Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 10.6. Latin America (LATAM)
    • 10.6.1. Overview
    • 10.6.2. Next-Generation Biomanufacturing Key Manufacturers in Latin America
    • 10.6.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.6.4. LATAM Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
    • 10.6.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.6.6. LATAM Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 10.6.7. LATAM Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.6.8. Brazil
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.8.3. Brazil Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.6.8.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.8.5. Brazil Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.6.8.6. Brazil Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.6.9. Mexico
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.9.3. Mexico Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.6.9.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.9.5. Mexico Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.6.9.6. Mexico Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.6.10. Argentina
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.10.3. Argentina Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.6.10.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.10.5. Argentina Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.6.10.6. Argentina Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.6.11. Colombia
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.11.3. Colombia Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.6.11.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.11.5. Colombia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.6.11.6. Colombia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.6.12. Rest of LATAM
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.12.3. Rest of LATAM Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.6.12.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.12.5. Rest of LATAM Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.6.12.6. Rest of LATAM Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 10.7. Middle East and Africa (MEA)
    • 10.7.1. Overview
    • 10.7.2. Next-Generation Biomanufacturing Key Manufacturers in Middle East and Africa
    • 10.7.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.7.4. MEA Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
    • 10.7.5. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.7.6. MEA Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 10.7.7. MEA Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.7.8. Saudi Arabia
      • 10.7.8.1. Overview
      • 10.7.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.7.8.3. Saudi Arabia Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.7.8.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.7.8.5. Saudi Arabia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.7.8.6. Saudi Arabia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.7.9. United Arab Emirates
      • 10.7.9.1. Overview
      • 10.7.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.7.9.3. United Arab Emirates Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.7.9.4. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.7.9.5. United Arab Emirates Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.7.9.6. United Arab Emirates Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.7.10. Israel
      • 10.7.10.1. Overview
      • 10.7.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.7.10.3. Israel Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.7.10.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.7.10.5. Israel Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.7.10.6. Israel Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.7.11. Turkey
      • 10.7.11.1. Overview
      • 10.7.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.7.11.3. Turkey Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.7.11.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.7.11.5. Turkey Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.7.11.6. Turkey Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.7.12. Algeria
      • 10.7.12.1. Overview
      • 10.7.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.7.12.3. Algeria Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.7.12.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.7.12.5. Algeria Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.7.12.6. Algeria Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.7.13. Egypt
      • 10.7.13.1. Overview
      • 10.7.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.7.13.3. Egypt Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.7.13.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.7.13.5. Egypt Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.7.13.6. Egypt Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.7.14. Rest of MEA
      • 10.7.14.1. Overview
      • 10.7.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.7.14.3. Rest of MEA Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.7.14.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.7.14.5. Rest of MEA Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.7.14.6. Rest of MEA Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)

11. Key Vendor Analysis- Next-Generation Biomanufacturing Industry

  • 11.1. Competitive Benchmarking
    • 11.1.1. Competitive Dashboard
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
  • 11.3. Applikon Biotechnology BV (Netherlands),
  • 11.4. bbi-biotech GmbH (Germany),
  • 11.5. Danaher Corporation (US),
  • 11.6. Eppendorf AG (Germany), Esco Group of Companies (US),
  • 11.7. GEA Group Aktiengesellschaft (Germany),
  • 11.8. Meissner Filtration Products, Inc. (US),
  • 11.9. Merck KGaA (Germany),
  • 11.10. PBS Biotech, Inc. (US),
  • 11.11. Pierre Guerin (France),
  • 11.12. Sartorius AG (Germany),
  • 11.13. Shanghai Bailun Biotechnology Co. Ltd. (China),
  • 11.14. Solaris Biotechnology Srl. (Italy),
  • 11.15. Thermo Fisher Scientific Inc. (US),
  • 11.16. ZETA GmbH (Austria),
  • 11.17. Other

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제